Proposed Data Collection Submitted for Public Comment and Recommendations, 4887-4889 [2022-01886]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Pages 4887-4889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01886]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-22CC; Docket No. CDC-2022-0010]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public

[[Page 4888]]

burden and maximize the utility of government information, invites the 
general public and other federal agencies the opportunity to comment on 
a proposed and/or continuing information collection, as required by the 
Paperwork Reduction Act of 1995. This notice invites comment on a 
proposed information collection project titled Assessment for the Be 
Antibiotics Aware Consumer and Healthcare Professional (HCP) Campaign. 
Individuals who have opted to be contacted for surveys will be screened 
for eligibility and given access to an online survey to assess the Be 
Antibiotics Aware campaign, which is designed to optimize antibiotic 
prescribing and use.

DATES: CDC must receive written comments on or before April 1, 2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0010 by either of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Assessment for the Be Antibiotics Aware Consumer and HCP Campaign--
New--National Center for Emerging and Zoonotic Infectious Diseases 
(NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Antibiotic resistance (AR) is one of the most urgent threats to 
public health in the United States. Antibiotic resistant bacteria have 
grown more virulent, prevalent, and diverse and can spread between 
human and animals. Each year there are more than 2.8 million 
antibiotic-resistant infections in the United States and 35,000 
individuals die as a result. At least 30 percent of antibiotics 
prescribed to outpatients and emergency departments are unnecessary 
which amounts to 47 million excess prescriptions per year. One of the 
main side effects of taking antibiotics is alteration of the microbiome 
which could lead to infections such as C. difficile, the inability to 
treat infections, prolonged illness, or even death. Risk factors for AR 
include lack of knowledge, sub-therapeutic doses, excessive use, 
antibiotic residues, and incorrect storage. In addition, there can be 
impacts on productivity, healthcare costs, and it can serve as a drain 
on the economy.
    The National Action Plan calls for federal agencies to accelerate 
their response to AR. The goals of the National Action Plan are to 
coordinate strategic actions in order to ``improve the health and well-
being of all Americans across the One Health Spectrum.'' In 2015, the 
National Action Plan set off with the goal to reduce inappropriate 
outpatient antibiotic use by 50 percent by 2020. It prioritizes 
prevention and control to prevent infection and reduce the need for 
antibiotics. Their approach, One Health, recognizes the inter-
relatedness of humans, animals, and the environment. One way to 
decrease the use of unnecessary antibiotic prescriptions is through 
antibiotic stewardship.
    The goals of the Be Antibiotics Aware campaign are to seek 
optimization of antibiotic prescribing and use in order to improve 
patient safety and healthcare quality and to combat AR by raising 
knowledge and awareness, and motivating behavior change among target 
consumer and HCP audiences. Online panel surveys will be utilized to 
recruit participants. Surveys will be distributed to consumer target 
groups both pre- and post-campaign.
    Consumer audiences include:
    (1) Spanish speaking women, ages 18-64,
    (2) Healthy adults who visit urgent care, ages 18-64,
    (3) Community dwelling older adults, ages 65+, and
    (4) Family caregivers of nursing home (long-term care) residents.
    HCP audiences include:
    (1) Hospitalists,
    (2) Dentists,
    (3) Community pharmacists,
    (4) Physicians and advanced practice providers in nursing homes, 
and
    (5) Nurses in nursing homes.
    This evaluation will assist CDC in determining if the Be 
Antibiotics Aware media campaign was successful in raising knowledge 
and awareness and motivating behavior change among target consumer and 
HCP audiences in select markets. The information gathered from this 
evaluation will also be used to inform refinement and implementation of 
the campaigns (materials and tactics).
    CDC requests OMB approval for an estimated 68 annual burden hours. 
There is no cost to respondents other than their time.

[[Page 4889]]



                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                              Average
                                                                                             Number of       Number of      burden per     Total burden
              Type of respondents                               Form name                   respondents    responses per   response (in     (in hours)
                                                                                                            respondent        hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Consumers......................................  Be Antibiotics Aware Consumer Pilot                  50               1           20/60              17
                                                  Assessment Pretest.
Consumers......................................  Be Antibiotics Aware Consumer Pilot                  50               1           20/60              17
                                                  Assessment Posttest.
HCPs...........................................  HCP Be Antibiotics Aware Campaign                    50               1           20/60              17
                                                  Pretest.
HCPs...........................................  Be Antibiotics Aware Posttest..........              50               1           20/60              17
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............              68
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-01886 Filed 1-28-22; 8:45 am]
BILLING CODE 4163-18-P